Is this you?
Request access for UC San Diego with your @cardiometabolic-syndrome work email. Intera will contact you to verify and set up your account — nothing auto-publishes.
UC San Diego
Unclaimed profileAcademic Network · San Diego, California · ~2 sites
Intera lens
ICP 7Lift (cardio sample) 0.71Recruit soph 0.29
Quality Scorecard (1–100)
Overall83Recruit59Ops86Sponsor97Ther99
Performance (observed)
Historical trials
800
Completed
309
Terminated/Withdrawn
104
Completion rate
75%
Active now
357
Phase 2
304
Phase 3
303
Realized enrollment
359,112
First study year
1991
Years active
35
Match confidence
low (approx)
Enrollment velocity (inf)
10,260
Therapeutic
Areas
Cardiometabolic syndrome, cardiovascular disease, type 2 diabetes, preventive cardiology, lipid disorders
Specialties
Cardiometabolic syndrome, cardiology, endocrinology/metabolic
Breadth (conditions)
1,926
States
California
Recruitment (web observed)
Trial Finder
Yes
Advertises recruitment
Yes
Capability notes
High - academic medical center, NIH funding, national reputation
Relationships
Sponsors
National Cancer Institute (NCI); University of California, San Diego; Alliance for Clinical Trials in Oncology; AbbVie; SWOG Cancer Research Network; NRG Oncology
CROs
Clinipace Worldwide; Covance; Crohn's and Colitis Foundation; ICON Clinical Research; ICON plc; IQVIA Biotech
Partnerships
Academic medical center
Owner / parent
University of California - NIH funded (Principal Investigator on R01 grant), Department of Defense, American Heart Association
Funding
University-funded
Acquisitions
N
Capacity & people
Investigators
—
Coordinators
—
CEO
Unknown
VP Clinical Ops
Unknown
VP Site Ops
Unknown
VP Recruitment
Pam R. Taub, MD (Director of Preventive Cardiology, Director of CVRC)
Emails
preventivecvresearch@health.ucsd.edu, golombresearch@ucsd.edu
Tech & DCT
Builds tech
Builds tech internally (myCircadianClock app for real-time tracking)
Tech stack
Wearable/mobile devices, continuous glucose monitors, smartphone app (myCircadianClock), actiwatches
Recruiting visible
Y
Notes
Leading academic cardiometabolic research program. ClinicalTrials.gov validation: 4 active recruiting cardiometabolic trials. Tech-forward with custom mobile app development and wearable integration. Strong focus on behavioral/tech interventions for cardiometabolic disease. NIH funding and academic rigor.
Recommendation features (sample indication)
Ind fit 1.00Liftability 0.71Overall83
FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.